Telehealth company Amwell priced its stock between $14 and $16 per share for its planned IPO and partnered with Google for its cloud services.
Telehealth company Amwell hopes to raise $560m in an initial public offering, according to an S-1 registration statement. The company said it will offer 35 million shares of its class A common stock priced between $14 and $16 a share.
Morgan Stanley, Goldman Sachs & Co. LLC and Piper Sandler will act as the joint bookrunning managers for the proposed...
Create an account to read this article
Already a subscriber?
Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.
Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.
An interactive look at medtech and diagnostics deals made during June 2025. Data courtesy of Biomedtracker.
